Acutaas Chemicals Ltd (ACUTAAS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Acutaas Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Transcript for Earnings call for Q2 FY 2027 Financial Results held on October 27, 2026 is attached
Transcript · 02 Nov 2026, 11:27 pm
Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 is attached.
Change in Management · 02 Nov 2026, 11:20 pm
Acutaas Chemicals Appoints Ashish Kumar Pandey as Operations AVP and Restructures Management Acutaas Chemicals Limited appointed Dr. Ashish Kumar Pandey as Assistant Vice President – Operations (Cluster Head – Unit 2 & 3), designated as Senior Management Personnel (SMP), effective 2nd Nov'26. Dr. Pandey brings over 30 years of operational experience across agrochemicals, specialty chemicals, and pharmaceutical intermediates. Consequently, Anurag Shukla (GM – Operations, Unit 2) and Uday Desai (GM – Operations, Unit 3) ceased to be designated as SMP due to internal reporting realignments, as both will now report directly to Dr. Pandey while retaining their respective operational roles.
Recording to earnings call held on October 27, 2026 is attached.
Audio / Video · 27 Oct 2026, 11:36 pm
Acutaas Chemicals Releases Audio Recording for Earnings Call Held on Oct'26 Acutaas Chemicals Limited (formerly Ami Organics Limited) has made available the audio recording of its earnings call conducted on 27th Oct'26 at 4:00 PM IST. The disclosure, submitted pursuant to Regulations 30 and 46(2) of SEBI LODR Regulations, follows the company's prior intimation dated 22nd Oct'26. The recording is accessible to investors via the company’s official website and direct backend link.
Investor Presentation on financial results for the second quarter and half year ended as on September 30, 2026 is enclosed.
Investor Presentation · 27 Oct 2026, 6:35 pm
Acutaas Chemicals Delivers Robust Q2 FY27 Results and Upgrades Full-Year Guidance Acutaas Chemicals reported strong Q2 FY27 results, with revenue rising 42.7% YoY to ₹4,369 Mn, EBITDA surging 84.6% YoY to ₹1,760 Mn (margin expanded to 40.3%), and PAT climbing 71.4% YoY to ₹1,231 Mn. Growth was powered by Pharma Intermediates (up 53.1% YoY to ₹4,020 Mn), offsetting softness in Specialty Chemicals. Ahead of schedule, the company inaugurated its South Korea facility for semiconductor chemicals. Backed by solid visibility, management raised FY27 revenue growth guidance to ~30% and EBITDA margin guidance to 38–40%.
Press Release discussing the financial results for the second quarter and half year ended as on September 30, 2026 is attached.
Press Release · 27 Oct 2026, 6:29 pm
Acutaas Chemicals Delivers Strong Q2 FY27 Results and Upgrades Annual Guidance Acutaas Chemicals reported robust Q2 FY27 results, with revenue from operations surging 42.7% YoY to ₹4,369mn, led by pharmaceutical intermediates. EBITDA jumped 84.6% YoY to ₹1,760mn as EBITDA margin expanded 920 bps YoY to 40.3%, while PAT rose 71.4% YoY to ₹1,231mn with margins at 28.2%. The company inaugurated its South Korea facility ahead of schedule to produce high-purity semiconductor chemicals. Backed by strong order visibility, management revised FY27 revenue growth guidance upward from 25% to ~30% and raised EBITDA margin guidance to 38-40%.
Acutaas Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 27 Oct 2026, 6:20 pm
Acutaas Chemicals Reports Robust Q2 FY27 Financial Results Acutaas Chemicals reported a 42.7% YoY increase in consolidated revenue from operations to ₹43,691.64 lakhs for the quarter ended 30th Sep'26, up from ₹30,619.58 lakhs in Q2 FY26. Consolidated profit after tax grew 71.4% YoY to ₹12,314.25 lakhs compared to ₹7,185.59 lakhs in the prior-year period. Diluted EPS stood at ₹15.24 versus ₹8.82 YoY. Step-down subsidiary Indichem Inc. inaugurated its ~₹200 crore (KRW 30 billion) semiconductor materials plant in South Korea on 28th Aug'26, which is currently undergoing trial runs.
Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 is enclosed.
Financial Result · 27 Oct 2026, 6:16 pm
The Board of Directors of the Company at their meeting held on Friday, October 27, 2026, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company ....
Outcome · 27 Oct 2026, 6:10 pm
Acutaas Chemicals Approves Q2 and H1 FY27 Financial Results Acutaas Chemicals Limited (formerly Ami Organics Limited) announced that its Board of Directors approved the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26 during its meeting on 27th Oct'26. The board also reviewed and approved the balance sheet, cash flow statement for the half year, and took note of the Limited Review Report submitted by statutory auditors M/s Maheshwari & Co., Chartered Accountants.
Equirus Securities has organised an Earnings Conference Call on Tuesday, October 27, 2026 at 4.00 P.M. (IST) to discuss the financial results of the Company for the second quarter and half ....
Intimation · 27 Oct 2026, 4:00 pm
Acutaas Chemicals Schedules Q2 & 1HFY27 Earnings Conference Call Acutaas Chemicals Limited (formerly Ami Organics Limited) has scheduled its Q2 & 1HFY27 earnings conference call for 27th Oct'26 at 4:00 PM IST, organized by Equirus Securities. The call will follow the announcement of financial results for the period ended 30th Sep'26. Key management participants include Chairman and Managing Director Naresh Patel, CFO Bhavin Shah, and President - Strategy Abhishek Patel, who will discuss performance followed by a Q&A session.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 27 Oct 2026, 5:30 am
ACUTAAS CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 27 Oct 2026, 5:30 am
Acutaas Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve Unaudited standalone & consolidated ....
Intimation · 27 Oct 2026, 5:30 am
Acutaas Chemicals Schedules Board Meeting to Approve Q2 Results Acutaas Chemicals Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The meeting will be preceded by an Audit Committee review on the same day. In compliance with insider trading regulations, the trading window for designated persons remains closed from 1st Oct'26 through 29th Oct'26, reopening on 30th Oct'26.
Completion of the Acquisition of the shares of the Step-down Subsidiary - Enchem Ami Organics Private Limited as per details attached.
Others (Uncategorized) · 17 Oct 2026, 8:38 pm
Acutaas Chemicals Completes 100% Acquisition of Enchem Ami Organics Acutaas Chemicals Limited completed the acquisition of 100% equity share capital in step-down subsidiary Enchem Ami Organics Private Limited on 17th Oct'26. The transaction involved the transfer of 10,000 equity shares with a face value of Rs. 10 each from subsidiary Acutaas Chemicals Electrolytes Private Limited. Following the completion of this share transfer, Enchem Ami Organics Private Limited has transitioned into a direct wholly-owned subsidiary of Acutaas Chemicals Limited.
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is enclosed.
Change in Management · 27 Sept 2026, 12:48 am
Acutaas Chemicals Approves Re-Appointment of Whole Time and Independent Directors Shareholders of Acutaas Chemicals Limited (formerly Ami Organics Limited) approved the re-appointment of Mr. Ram Mohan Lokhande as Whole Time Director and Mrs. Anita Bandyopadhyay as Non-Executive Independent Director at the 19th AGM on 24th Sep'26. Both appointments are for five-year terms spanning 8th Feb'27 to 7th Feb'32, including approval of remuneration. Mr. Lokhande oversees API manufacturing, plant operations, and project management, while Mrs. Bandyopadhyay contributes strategic HR and organizational capability expertise. Neither director is related to key managerial personnel or debarred by SEBI.
Voting Results and Scrutinizers Report for the Annual General Meeting of the Company held on September 24, 2026 is attached.
Annual General Meeting · 27 Sept 2026, 12:37 am
Board of Directors have approved the acquisition of equity shares of step down subsidiary company as per details enclosed.
Others (Uncategorized) · 25 Sept 2026, 1:06 am
Acutaas Chemicals to Acquire 100% Stake in Step-Down Subsidiary EAOPL Acutaas Chemicals Limited has approved the acquisition of a 100% equity stake in its step-down subsidiary, Enchem Ami Organics Private Limited (EAOPL), from Acutaas Chemicals Electrolytes Private Limited for a cash consideration of Rs. 1,00,000 (10,000 shares at Rs. 10 each). Following the transaction, expected to close within one month, EAOPL will become a direct wholly owned subsidiary in line with the core specialty chemicals business. Incorporated on 6th Jun'24, EAOPL reported nil revenue across FY24-25 and FY25-26.
Disclosure of events of the 19th Annual General Meeting held on Thursday, September 24, 2026 is attached.
Annual General Meeting · 24 Sept 2026, 10:52 pm
Intimation of Schedule of Investor Conference/Meet as per details attached.
Intimation · 22 Sept 2026, 6:17 pm
Acutaas Chemicals Schedules Investor Interaction at PL Capital Conference Acutaas Chemicals Limited (formerly Ami Organics Limited) announced that company officials will participate in person at the PL Capital Mid & Small Cap Conference 2026 on 28th Sep'26 in BKC, Mumbai. The management will engage in one-on-one and group meetings with investors and analysts. The company confirmed that no unpublished price-sensitive information will be shared during the interactions.
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 is attached.
Others (Uncategorized) · 10 Sept 2026, 11:29 pm
Acutaas Chemicals Secures 20-Year Indian Patent for Chemical Synthesis Process The Patent Office, Government of India, granted Acutaas Chemicals Limited a 20-year process patent on 10th Sep'26 for its invention titled "A PROCESS FOR PREPARING 2,4-DIMETHYLTHIOPHENOL", effective from the filing date of 21st Sep'17. Indigenously developed at the company's in-house R&D centre, this addition expands Acutaas Chemicals' total granted patent portfolio to 11 for its proprietary processes and technologies.
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 in respect of inauguration of Pilot Plant today at Unit-1 Sachin is enclosed.
Others (Uncategorized) · 04 Sept 2026, 5:34 pm
Communication to shareholders issued in respect of deduction of TDS on Dividend , is herewith enclosed.
Dividend · 30 Aug 2026, 1:58 am
Acutaas Chemicals Details FY26 Final Dividend and TDS Rules Acutaas Chemicals' board has recommended a final dividend of Rs. 2.50 per share (face value Rs. 5) for FY26, subject to shareholder approval at the AGM on 24 Sep'26. The record date is set for 17 Sep'26. The company has communicated the process for Tax Deducted at Source (TDS) on this dividend. For resident shareholders, the TDS rate is 10% with a valid PAN and 20% without. Non-resident TDS is 20%, subject to tax treaty benefits. Documents for lower/nil TDS must be submitted by 15 Sep'26.
Intimation of Record date fixed for the purpose of Final Dividend for the FY 2025-26 is herewith enclosed.
Dividend · 30 Aug 2026, 1:52 am
Acutaas Chemicals Announces Final Dividend Record Date for FY26 Acutaas Chemicals has set Thu, 17 Sep'26 as the record date for its FY26 final dividend. Shareholders on record will be eligible for a dividend of ₹2.50 per share (50% of ₹5 face value). The dividend is subject to shareholder approval at the Annual General Meeting (AGM) scheduled for Thu, 24 Sep'26. Payment will be made within 30 days of the AGM declaration.
BRSR Report for the FY 2025-26 is herewith enclosed.
Others (Uncategorized) · 30 Aug 2026, 1:48 am
Acutaas Chemicals Submits Business Responsibility & Sustainability Report for FY26 Acutaas Chemicals submitted its Business Responsibility and Sustainability Report for FY 2025-26 on 29th Aug'26. Key business activities remain the manufacturing of pharmaceutical intermediates and specialty chemicals, with exports contributing 76% of total turnover. Sourcing from MSMEs/small producers was 40.23% of total inputs, up from 34% YoY. The company reported zero employee/worker fatalities for FY26. Total Scope 1 and 2 GHG emissions were 51,404.93 MTCO2e. All permanent employees (940) receive more than minimum wage. The company committed ₹295 Lakhs towards CSR activities for the year.
Annual Report for the FY 2025-26 is herewith enclosed.
Others (Uncategorized) · 30 Aug 2026, 1:42 am
Notice of the 19th Annual General Meeting of Company scheduled to be held on Thursday, September 24, 2026 at 11.30 A.M. IST is enclosed herewith.
Annual General Meeting · 30 Aug 2026, 1:34 am